EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access

Twenty-four-hour urine oxalate and risk of chronic kidney disease

Marja Puurunen, Caroline Kurtz, Alistair Wheeler, Kyra Mulder, Kyle Wood, Anna Swenson, Gary Curhan

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfad221 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Marja Puurunen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Synlogic Therapeutics, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Oxalates. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Synlogic, Inc., NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess whether 24-h urine oxalate (UOx) excretion is a risk factor for incident chronic kidney disease (CKD).

Methods

This longitudinal observational USA-based study included 426 896 individuals aged ≥18 years with no CKD at baseline and with at least one UOx, and at least 6 months of baseline and 6 months of follow-up data. Of these, 11 239 (2.6%) had an underlying malabsorptive condition. Incident CKD, defined by relevant International Classification of Diseases codes, was identified from a multi-source data cloud containing individual-level healthcare claims and electronic medical records data. The association between categories of UOx and incident CKD was modeled using logistic regression adjusting for age, sex, race, body mass index, baseline urine calcium, urine citrate, urine volume, tobacco use, hypertension, diabetes, malabsorption and cardiovascular disease.

Results

Mean follow-up time was 38.9 months (standard deviation 21.7). Compared with individuals with UOx <20 mg/24 h, the odds of developing incident CKD increased for UOx 20–29 mg/24 h [multivariable-adjusted odds ratio (MVOR) 1.14 (95% CI 1.07, 1.21)] through 80+ mg/24 h [MVOR 1.35 (1.21, 1.50)] and was statistically significant for each UOx category. A similar pattern was seen in the subgroup with a malabsorptive condition though the magnitudes of association were larger, with the odds of developing incident CKD increased for UOx 20–29 mg/24 h [MVOR 1.50 (1.03, 2.20)] through 80+ mg/24 h [MVOR 2.34 (1.50, 3.63)] as compared with UOx <20 mg/24 h.

Conclusions

The risk of incident CKD increases with increasing 24-h UOx excretion. Future studies should examine whether reducing UOx diminishes the risk of developing CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicOxalatesHumansFemaleMaleMiddle AgedRisk FactorsLongitudinal StudiesAdultFollow-Up StudiesAgedIncidencePrognosisGlomerular Filtration RateUnited States

Stichwörter der Autor:innen

chronic kidney diseasemalabsorptionprospective studyreal-world dataurine oxalate

Substanzen

Oxalates

Autor:innen und Institutionen

  • Synlogic Therapeutics, Cambridge, MA, USA.
  • OM1, Inc., Boston, MA, USA.
  • University of Alabama, Birmingham, AL, USA.

Förderung

  • Synlogic, Inc.
  • NIH

Zitieren

APA

Puurunen, M., Kurtz, C., Wheeler, A., Mulder, K., Wood, K., Swenson, A., & Curhan, G. (2024). Twenty-four-hour urine oxalate and risk of chronic kidney disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfad221

Vancouver

Puurunen M, Kurtz C, Wheeler A, Mulder K, Wood K, Swenson A, et al. Twenty-four-hour urine oxalate and risk of chronic kidney disease. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfad221

BibTeX
@article{Puurunen2024,
  author = {Puurunen, Marja and Kurtz, Caroline and Wheeler, Alistair and Mulder, Kyra and Wood, Kyle and Swenson, Anna and Curhan, Gary},
  title = {Twenty-four-hour urine oxalate and risk of chronic kidney disease},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfad221}
}
Kostenlos starten →